Affibody AB

Ablynx NV

This company develops nanobody-based therapeutic proteins to treat inflammation, haematology, oncology and pulmonary diseases for pharmaceutical partners and patients.

Precirix

This biotechnology company develops precision radiopharmaceuticals using camelid single-domain antibodies to treat patients with various types of cancer.

Oncopeptides AB

This biotech company develops targeted therapies for patients with difficult-to-treat hematological diseases, specifically focusing on multiple myeloma treatments.

Zymeworks

The company develops antibody-based biotherapeutics for cancer and inflammatory diseases, which it licenses to global pharmaceutical partners to treat patients.

Radiant Biotherapeutics

This company develops multi-specific antibody therapies to treat patients with cancer and infectious diseases.

Full-Life Technologies

This company develops radiopharmaceuticals and radionuclide drug conjugates to treat cancer patients through targeted alpha therapy.

Akiram Therapeutics

This biotech company develops targeted radiopharmaceuticals and radioimmunotherapies for patients with solid tumours and metastatic cancers.

Aqilion

This biotech company develops early-stage drug treatments for chronic inflammatory diseases to supply pharmaceutical and biotechnology partners with new clinical development projects.